Oral treatment for high lipoprotein(a) and heart risk
This study tests an oral medicine (HRS-5346) to lower lipoprotein(a), a type of fat in the blood linked to heart problems. It might help people with high levels who are at increased risk for heart attacks or strokes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Are 18 years or older
- Have high lipoprotein(a) (≥150 nmol/L) in a blood test
- Have a high risk of heart problems or stroke
- Have a body mass index (BMI) between 18.5 and 40
- Have stable health and be willing to follow the study plan
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests different forms of an experimental medicine called HRS-5346 to see how the body absorbs them. It is for healthy people aged 18 to 45, and the results will help decide which version to use in future studies.
This trial tests whether a new once-daily pill called SAL0137 can safely lower Lp(a), a type of cholesterol that raises heart attack and stroke risk. It's for adults with high Lp(a) and other heart risk factors, like prior heart problems or diabetes.
This trial tests a new medicine called SRSD216 for people with high levels of lipoprotein (a), a type of fat in the blood that can increase heart disease risk. The study aims to see if the drug is safe and effective at lowering these levels.
This trial tests two experimental drugs designed to lower lipoprotein(a)—a type of cholesterol particle linked to heart disease—in people whose levels remain high despite taking statins (cholesterol-lowering medications). The goal is to see if these drugs can safely reduce this risk factor.
This trial tests a new injection (SYH2068) designed to lower lipoprotein(a), a type of cholesterol linked to heart disease. You may qualify if you have high lipoprotein(a) levels and either existing heart disease or significant risk factors for it.
This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.
Hear when a new Lipoprotein Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.